Investors & Media

Investor FAQs

Investors & Media

Investor FAQs

Show All
Where is Day One Biopharmaceuticals’ corporate headquarters?

Our corporate headquarters is located at 1800 Sierra Point Parkway, Suite 200, Brisbane, CA 94005.

Where is Day One Biopharmaceuticals incorporated?

We are incorporated in the State of Delaware.

When did Day One Biopharmaceuticals go public?

Our initial public offering (IPO) occurred on May 27, 2021.

What is Day One Biopharmaceuticals’ fiscal year end?

Our fiscal year end is December 31.

How is Day One Biopharmaceuticals’ stock traded?

We are traded on the NASDAQ Global Select Market under the ticker symbol “DAWN“, and our CUSIP number is 23954D 109.

Does Day One Biopharmaceuticals pay dividends?

We do not pay a dividend.

Who is Day One Biopharmaceuticals’ transfer agent?

Our transfer agent is:

Equiniti Trust Company, LLC
48 Wall St., Floor 23, New York, NY 10005
Website: equiniti.com/us
Email: HelpAST@equiniti.com
Phone (U.S.): (800) 937-5449
Phone (International): (718) 921-8124

Who is Day One Biopharmaceuticals’ independent auditors?

Our independent auditors are PricewaterhouseCoopers LLP.

Who is Day One Biopharmaceuticals’ legal counsel?

Our legal counsel is Fenwick & West LLP, San Francisco, California. 

How can I view documents Day One Biopharmaceuticals has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?

Our SEC filings can be found here.

Investor Contact

Investor Relations
investors@dayonebio.com

Media Contact

Laura Cooper
Media@dayonebio.com

Helpful Tools